The content on this site is intended for healthcare professionals only
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Choosing 1st line TKI Wisely in patients with CML
Common Sense Oncology in head & neck cancers
Head & Neck - BMC Data
Amivantamab-lazertinib continue to show benefit as a first-line standard-of-care for EGFR-mutated advanced NSCLC
TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC
Choosing the right patients for transplant
CAR-T - Choosing Wisely
BMC data: Paediatric Oncology
TARGIT trial in intraoperative radiotherapy
